Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21667 | 25137852 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1]. | 2014 | Details |
| A21676 | 25127738 | Trends Endocrinol Metab | Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism. | 2014 | Details |
| A21707 | 25104497 | Am J Physiol Gastrointest Liver Physiol | Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver. | 2014 | Details |
| A21713 | 25100370 | Endocr Pract | Clinical profile of nonalcoholic Fatty liver disease among young patients with type 1 diabetes mellitus seen at a diabetes speciality center in India. | 2014 | Details |
| A21718 | 25097051 | Arab J Gastroenterol | Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt. | 2014 | Details |
| A21721 | 25091357 | Obes Res Clin Pract | Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria. | 2013 | Details |
| A21723 | 25091053 | Clin Pharmacokinet | Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus. | 2014 | Details |
| A21735 | 25083080 | World J Gastroenterol | Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? | 2014 | Details |
| A21754 | 25071314 | World J Gastroenterol | Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? | 2014 | Details |
| A21769 | 25060337 | Sci Rep | Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. | 2014 | Details |
| A21771 | 25057109 | J Mol Endocrinol | oxLDL induces injury and defenestration of human liver sinusoidal endothelial cells via LOX1. | 2014 | Details |
| A21774 | 25053716 | Gut | Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. | 2014 | Details |
| A21783 | 25047370 | Wien Med Wochenschr | Intracellular lipid accumulation and shift during diabetes progression. | 2014 | Details |
| A21784 | 29159094 | J Clin Transl Endocrinol | The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A21787 | 25045276 | Clin Exp Gastroenterol | Molecular pathways in non-alcoholic fatty liver disease. | 2014 | Details |
| A21788 | 25045230 | J Korean Med Sci | Clinical significance of non-alcoholic fatty liver disease as a risk factor for prehypertension. | 2014 | Details |
| A21797 | 25039333 | J Gastroenterol Hepatol | Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A21820 | 25024596 | World J Gastroenterol | Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. | 2014 | Details |
| A21823 | 25024593 | World J Gastroenterol | Modern approach to the clinical management of non-alcoholic fatty liver disease. | 2014 | Details |
| A21828 | 25019654 | Gen Comp Endocrinol | The effect of recombinant adeno-associated virus-adiponectin (rAAV2/1-Acrp30) on glycolipid dysmetabolism and liver morphology in diabetic rats. | 2014 | Details |
| A21829 | 25019404 | Child Obes | Children's Hospital Association consensus statements for comorbidities of childhood obesity. | 2014 | Details |
| A21844 | 25004910 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic. | 2014 | Details |
| A21855 | 24997826 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | Effect of piglitazone and metformin on retinol-binding protein-4 and adiponectin in patients with type 2 diabetes mellitus complicated with non-alcohol fatty acid liver diseases. | 2014 | Details |
| A21882 | 24978903 | Nat Commun | TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A21889 | 24976563 | Hepatol Res | Influence of lifestyle-related diseases and age on the development and progression of non-alcoholic fatty liver disease. | 2014 | Details |
| A21895 | 24975463 | Diabet Med | Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India. | 2014 | Details |
| A21902 | 24973357 | J Endocrinol | 20 years of leptin: leptin in common obesity and associated disorders of metabolism. | 2014 | Details |
| A21906 | 24968846 | Nan Fang Yi Ke Da Xue Xue Bao | [Therapeutic effect of saxagliptin in rat models of nonalcoholic fatty liver and type 2 diabetes]. | 2014 | Details |
| A21909 | 24968200 | Br J Nutr | Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats. | 2014 | Details |
| A21914 | 24966606 | World J Gastroenterol | Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease. | 2014 | Details |
| A21927 | 24961607 | Liver Transpl | Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. | 2014 | Details |
| A21928 | 24961024 | J Egypt Soc Parasitol | Assessment of the co-incidence between non alcoholic fatty liver disease and carotid atherosclerosis. | 2014 | Details |
| A21937 | 24952996 | Neurogastroenterol Motil | Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet. | 2014 | Details |
| A21945 | 24947350 | Diabetes | SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. | 2014 | Details |
| A21953 | 24939737 | Am J Physiol Endocrinol Metab | Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract. | 2014 | Details |
| A21964 | 24927647 | J Diabetes Complications | Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease. | 2014 | Details |
| A21972 | 24923363 | Hepatol Res | Hepatocellular carcinoma based on cryptogenic liver disease: The most common non-viral hepatocellular carcinoma in patients aged over 80 years. | 2014 | Details |
| A21973 | 24923289 | Horm Res Paediatr | Predictors of metabolic risk in childhood obesity. | 2014 | Details |
| A21990 | 24906975 | J Endocrinol Invest | Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women. | 2014 | Details |
| A21997 | 24901731 | JAAPA | An update on nonalcoholic fatty liver disease. | 2014 | Details |
| A22000 | 24901133 | Hepatogastroenterology | Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus. | 2014 | Details |
| A22003 | 24899308 | Nature | The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. | 2014 | Details |
| A22005 | 24898917 | Histopathology | Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients. | 2014 | Details |
| A22006 | 24897026 | Int J Mol Sci | Steatosis and steatohepatitis: complex disorders. | 2014 | Details |
| A22010 | 24893617 | J Diabetes | Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：. | 2014 | Details |
| A22019 | 24884478 | Climacteric | Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. | 2014 | Details |
| A22023 | 24870301 | Korean J Gastroenterol | [Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma]. | 2014 | Details |
| A22037 | 24858947 | PLoS One | The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats. | 2014 | Details |
| A22047 | 24851524 | Trop Gastroenterol | Non-alcoholic fatty liver disease among visitors to a hepatitis awareness programme. | 2014 | Details |
| A22048 | 24851523 | Trop Gastroenterol | Profile of patients with incidentally detected nonalcoholic fatty liver disease (IDNAFLD) in coastal eastern India. | 2014 | Details |
| A22062 | 24845341 | Liver Int | Reduced hepatic lipid content in Pten-haplodeficient mice because of enhanced AKT2/PKBβ activation in skeletal muscle. | 2014 | Details |
| A22065 | 24843757 | J Diabetes Investig | Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A22084 | 24829925 | J Diabetes Res | Ketosis onset type 2 diabetes had better islet β-cell function and more serious insulin resistance. | 2014 | Details |
| A22099 | 24823873 | Diabetes Metab Res Rev | Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes. | 2014 | Details |
| A22115 | 24806753 | Hepatology | FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. | 2014 | Details |
| A22121 | 24799990 | World J Hepatol | Pediatric non-alcoholic fatty liver disease: New insights and future directions. | 2014 | Details |
| A22130 | 24797416 | Sci Rep | Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. | 2014 | Details |
| A22133 | 24796105 | Nihon Rinsho | [Liver diseases]. | 2014 | Details |
| A22154 | 24784707 | Mol Cell Endocrinol | Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells. | 2014 | Details |
| A22164 | 24775330 | BMC Gastroenterol | Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. | 2014 | Details |
| A22166 | 24772746 | J Assoc Physicians India | Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). | 2013 | Details |
| A22179 | 24765505 | Clin Pract | Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease. | 2013 | Details |
| A22185 | 24760992 | Am J Physiol Endocrinol Metab | Mice lacking NOX2 are hyperphagic and store fat preferentially in the liver. | 2014 | Details |
| A22189 | 24758604 | BMC Gastroenterol | NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22197 | 24753460 | Nephrol Dial Transplant | Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. | 2014 | Details |
| A22214 | 24745923 | Curr Pharm Des | Psoriasis and Vascular Risk : An Update. | 2014 | Details |
| A22219 | 24743428 | Arterioscler Thromb Vasc Biol | Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. | 2014 | Details |
| A22220 | 24743120 | Georgian Med News | [Mechanisms of formation and progression of non-alcoholic fatty liver disease in type 2 diabetics]. | 2014 | Details |
| A22232 | 24736032 | Clin Res Hepatol Gastroenterol | Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. | 2014 | Details |
| A22238 | 24731669 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. | 2014 | Details |
| A22240 | 24730643 | J Gastroenterol Hepatol | Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice. | 2014 | Details |
| A22261 | 24709349 | Eur J Intern Med | Cholesterol control according to the presence of metabolic syndrome in coronary and diabetic patients. Relationship with non-alcoholic fatty liver disease. | 2014 | Details |
| A22277 | 24696459 | Diabetes Care | Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. | 2014 | Details |
| A22282 | 24692138 | Compr Physiol | Energy metabolism in the liver. | 2014 | Details |
| A22296 | 24685236 | J Acad Nutr Diet | Vegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth. | 2014 | Details |
| A22297 | 24684407 | Diabet Med | Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes. | 2014 | Details |
| A22300 | 24683323 | ScientificWorldJournal | A novel role of globular adiponectin in treatment with HFD/STZ induced T2DM combined with NAFLD rats. | 2014 | Details |
| A22306 | 24677740 | Pediatr Obes | Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery. | 2014 | Details |
| A22315 | 24669954 | Expert Opin Drug Metab Toxicol | Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. | 2014 | Details |
| A22318 | 24667697 | Clin Chim Acta | The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2014 | Details |
| A22320 | 24667349 | Eur J Gastroenterol Hepatol | Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22330 | 24656139 | Nutr Metab Cardiovasc Dis | Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes. | 2014 | Details |
| A22337 | 24652019 | Wien Klin Wochenschr | Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients. | 2014 | Details |
| A22340 | 24651470 | PLoS One | Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease. | 2014 | Details |
| A22347 | 24648300 | J Clin Lab Anal | M30 does not predict the severity of hepatosteatosis, whereas adiponectin level declined with increase of ALT and the severity of hepatic steatosis. | 2014 | Details |
| A22357 | 24639812 | Iran J Reprod Med | The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS. | 2013 | Details |
| A22358 | 24639417 | Diabetes Metab Res Rev | Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study. | 2014 | Details |
| A22371 | 24633023 | Intern Med | Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes. | 2014 | Details |
| A22377 | 24630507 | Arab J Gastroenterol | Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors? | 2014 | Details |
| A22391 | 24625239 | Diabetes Technol Ther | Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male Asian Indians with nonalcoholic fatty liver disease. | 2014 | Details |
| A22400 | 24616207 | Obesity (Silver Spring) | Macrophages and fibrosis in adipose tissue are linked to liver damage and metabolic risk in obese children. | 2014 | Details |
| A22409 | 24605611 | Lik Sprava | [Effect of probiotics on proinflammatory cytokines level in patients with type 2 diabetes and nonalcoholic fatty liver disease]. | 2013 | Details |
| A22414 | 24602757 | J Diabetes Complications | Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22419 | 24594085 | Nutr Metab Cardiovasc Dis | Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. | 2014 | Details |
| A22431 | 24583757 | J Clin Gastroenterol | Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis. | 2015 | Details |
| A22439 | 24577062 | J Appl Physiol (1985) | Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats. | 2014 | Details |
| A22445 | 24572250 | J Am Heart Assoc | Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. | 2014 | Details |
| A22450 | 24563239 | Dig Dis Sci | Plasma triglyceride levels may modulate hepatitis C viral replication. | 2014 | Details |
| A22459 | 24552858 | Ann Hepatol | The prevalence of nonalcoholic fatty liver disease in the Americas. | 2014 | Details |
| A22473 | 24532325 | J Sci Food Agric | Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high-fat diet/streptozotocin-induced diabetes rat model. | 2014 | Details |